Current cardiac diagnostics are insufficient in dealing with the rising burden of heart diseases

60% of US adults projected to have cardiovascular disease by 2050

30% of heart attacks are ‘silent’ in nature without any prior symptoms

Conventional techniques like Echo & BNP testing are too slow and expensive

PRESENTING

Suite of AI powered algorithms to detect silent cardiac indications with more in the pipeline

  • Diastolic Dysfunction
  • BNP Elevation
  • Low Ejection Fraction
  • Right Ventricular Dysfunction
  • Ventricular Hypertrophy
  • Atrial Enlargement
  • Left Ventricular Systolic Volume
  • Left Ventricular Diastolic Volume

Breakthrough ECG AI platform

Early diagnostics to initiate preventive therapies at the earliest

Simple and enhanced clinical workflow

Accessible ECG-AI Panel for better readability and physician understanding

1 million+

ECG signals from 100k+ patients for training and development of the model

4 live

deployments in collaboration with ECG manufacturers

7 partner

institutions for external validation and testing

0.80+ AUROC

score on all algorithms outperforming competitors and industry standards

Statistics

Carelog’s artificial intelligence algorithm is developed with diverse datasets and is undergoing rigorous testing in real world environments. We are continuously signing agreements with institutions and care providers to extend the benefits of our product to as many patients as possible.

  • Generalizable on diverse datasets across different countries and populations
  • Clinical publication and external validation in progress in collaboration with institutions and practices
  • Better AUROC performance than current gold-standards and competitors
  • Already deployed at 4 locations with deals in progress to roll out with ECG manufacturers.

The Powerhouse behind our algorithms – HridAI

In today’s world, access to quality data is the factor which defines the performance of artificial intelligence algorithms. Realizing this, we have developed HridAI, the world’s first breakthrough foundational model which powers all our algorithms.

  • Efficiency Redefined: Data collection is time-consuming and expensive, HridAI accelerates development, significantly reducing the resources needed.
  • Accessibility Expanded: Low data requirements enables healthcare providers and researchers to break the cost-barrier in harnessing AI.
  • Enhanced Explainability: Specifically marks the biologically relevant regions of the ECG in the report for better physician understanding.
  • Superior Performance: Outperforms traditional CNNs, ensuring reliable diagnostics even when data is scarce.

Data collection efficiency redefined

Requires just 10% of the data to train superior algorithms as compared to industry standards

Data acquisition costs redefined

Achieves superior training targets at just 10% of the costs compared to industry standards

Scalable performance across databases

Outperforms industry standard models with higher AUROC scores across multi-size datasets

Meet our team

Aman

Founder

Aman is a bio-engineer with 5+ years of experience in health tech. He has led developments of AI based cardiology software at Volta Medical. He is an IIT Kanpur and HEC Paris alumnus.

Sathis Kumar

Co-Founder

Sathis has 20+ years of tech experience in which he has built and scaled AI products for millions of users. He is an ex Meta Data Architect and has led 30+ tech teams during his stint as a VP at Xenovex.

Dr. Charu Ramanathan

Advisor

Dr. Charu is a repeat entrepreneur. She sold her previous venture CardioInsight to Medtronic for $100M+. She is also the co-founder and CEO of vitalxchange.

Dr. Jag Singh

Advisor

Dr. Jag Singh is a prolific author and thought leader in the cardiology healthcare segment. He is a Professor of Medicine at the Harvard Medical School. He is also the Founding Director of the Resynchronization and Advanced Cardiac Therapeutics Program, at the Massachusetts General Hospital Heart Center.